Skip to main content
Clinical Trials/DRKS00023464
DRKS00023464RecruitingNot Applicable

FLUORoscopy-Only based interventional closure of the left atrial appendage using the WATCHMAN FLX in patients with atrial fibrillation and contraindication against oral anticoagulation – feasibility and safety - Fluoro-FLX

Katholisches Krankenhaus St. Johan Nepomuk Erfurt0 sites30 target enrollmentStarted: December 11, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • age >18 Jahre
  • atrial fibrillation (paroxysmal, persistent, or permanent) with a scheduled interventional closure of the left atrial appendage
  • signed informed consent
  • exclusion of intracardiac thrombi by cardiac CT within 72 hours before the LAAC
  • no long-term interruption of oral anticoagulation before the LAAC (last dose of NOAC or low molecular weight heparin within 36 h before LAAC)

Exclusion Criteria

  • history of open heart surgery
  • unsuitable anatomy for LAAC due to cardiac CT
  • history of ASD/ PFO closure
  • contraindication regarding TEE
  • lack of informed consent
  • impossibility to perform follow-up TEE after 3 months

Investigators

Sponsor
Katholisches Krankenhaus St. Johan Nepomuk Erfurt

Similar Trials